CDZ173/Leniolisib, CDZ173/Leniolisib, CDZ173/Leniolisib clinical trials

A study to assess safety and tolerability, and explore efficacy of leniolisib for immune dysregulation in common variable immunodeficiency

This study is looking at a new medicine called leniolisib for people with Common Variable Immunodeficiency (CVID). It aims to check if the medicine is safe and well-tolerated, and to see if it could help improve some of the problems associated with CVID, like enlarged organs or lung issues.